BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2024 6:24:54 AM | Browse: 388 | Download: 745
 |
Received |
|
2023-12-29 06:40 |
|
Peer-Review Started |
|
2023-12-29 06:40 |
|
First Decision by Editorial Office Director |
|
2024-04-08 07:09 |
|
Return for Revision |
|
2024-04-08 07:09 |
|
Revised |
|
2024-04-18 06:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-06-07 02:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-07 09:39 |
|
Articles in Press |
|
2024-06-07 09:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-14 01:03 |
|
Publish the Manuscript Online |
|
2024-06-14 06:24 |
| ISSN |
2308-3840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Minireviews |
| Article Title |
Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ahmed Daoud, Karim Soliman, Maria Aurora Posadas Salas, Sakshi Vaishnav, Genta Uehara, Ahmed Abdelkader, Tibor Fulop and Michael J Casey |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmed Daoud, MD, PhD, Doctor, Doctor, Staff Physician, Department of Medicine, Division of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas street, Charleston, SC 29425, United States. ahmed.daoud84@yahoo.com |
| Key Words |
COVID-19; SARS-CoV-2 vaccination; Kidney; Renal transplant; Donor specific antibodies |
| Core Tip |
Our aim was to find out whether vaccines against Coronavirus disease 2019 (COVID-19) lead to an immunological response stimulating the production of de novo donor specific antibodies (DSAs) or increase in mean fluorescence intensity of pre-existing DSAs in kidney transplant recipients. We did a detailed literature search through December 2, 2023 using PubMed as the primary database. We used the following keywords: COVID-19, severe acute respiratory syndrome-coronavirus-2 vaccination, Kidney, Renal transplant, and DSAs. The results from related studies were collated and analyzed. |
| Publish Date |
2024-06-14 06:24 |
| Citation |
Daoud A, Soliman K, Posadas Salas MA, Vaishnav S, Uehara G, Abdelkader A, Fulop T, Casey MJ. Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far? World J Meta-Anal 2024; 12(2): 91264 |
| URL |
https://www.wjgnet.com/2308-3840/full/v12/i2/91264.htm |
| DOI |
https://dx.doi.org/10.13105/wjma.v12.i2.91264 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
